Get the Stockscreener App
2.69
3.93%
-0.11
After Hours:
2.68
-0.010
-0.37%
Nrx Pharmaceuticals Inc Stock (NRXP) Forecast
The Nrx Pharmaceuticals Inc (NRXP) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $8.5135, representing a +216.49% increase from the current price of $2.69. The highest analyst price target is $8.4644, and the lowest is $8.5626.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NRXP Price Target
Average 7.4323
(+176.29% Upside)
Is Nrx Pharmaceuticals Inc (NRXP) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.80 | Neutral |
| STOCH(9,6) | 14.47 | Buy |
| STOCHRSI(14) | 5.2347 | Buy |
| MACD(12,26) | 0.0963 | Sell |
| ADX(14) | 34.23 | Buy |
| William %R | -99.15 | Buy |
| CCI(14) | -63.72 | Neutral |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.067
Sell
|
3.101
Sell
|
| MA20 |
3.6875
Sell
|
3.1382
Sell
|
| MA50 |
2.3545
Buy
|
2.646
Buy
|
| MA100 |
1.8897
Buy
|
2.3265
Buy
|
| MA200 |
2.2638
Buy
|
2.4678
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, NRXP could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 5 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on NRXP, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 45.8 indicates that NRXP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 14.47 indicates that NRXP is oversold. This indicates that NRXP price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 5.2347 indicates that NRXP is oversold. This suggests that NRXP price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 34.23 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -63.72 indicates that NRXP is still oversold but not to an extreme extent.
Long-term NRXP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Nrx Pharmaceuticals Inc financial reports and earnings history, Nrx Pharmaceuticals Inc (NRXP) stock could reach $7.9167 by 2030, $62.35 by 2040 and $97.45 by 2050. See the projected annual prices until 2050 of the Nrx Pharmaceuticals Inc stock below:
- Nrx Pharmaceuticals Inc (NRXP) is expected to reach an average price of $32.89 in 2035, with a high prediction of $34.03 and a low estimate of $32.98. This indicates an $1,123% rise from the last recorded price of $2.69.
- Nrx Pharmaceuticals Inc (NRXP) stock is projected to chart a bullish course in 2040, with an average price target of $63.02, representing an $2,243% surge from its current level. The forecast ranges from a conservative $7.6405 to a sky-high $62.35.
- Our analysts predict Nrx Pharmaceuticals Inc (NRXP) to jump 1,547% by 2045, soaring from $44.36 to an average price of $44.29, potentially reaching $45.40. While $44.36 is the low estimate, the potential upside is significant.
- Nrx Pharmaceuticals Inc (NRXP) stock is expected to climb by 2050, reaching an average of $96.41, a $3,484% jump from its current level. However, a wide range of estimates exists, with high and low targets of $97.45 and $96.54, respectively, highlighting the market's uncertainty.
Nrx Pharmaceuticals Inc Stock (NRXP) Year by Year Forecast
Nrx Pharmaceuticals Inc Stock (NRXP) Price Forecast for 2025
Nrx Pharmaceuticals Inc Stock (NRXP) is expected to reach an average price of $7.5757 in 2025, with a high prediction of $9.1601 and a low estimate of $5.9914. This indicates an +181.63% rise from the last recorded price of $2.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $8.4063 | $8.5626 | $8.4644 | +212.50% |
| April, 2025 | $9.0228 | $9.0655 | $9.1601 | +235.42% |
| May, 2025 | $8.7132 | $8.7432 | $8.8576 | +223.91% |
| June, 2025 | $8.2456 | $8.3877 | $8.5964 | +206.53% |
| July, 2025 | $8.0049 | $8.0401 | $8.1266 | +197.58% |
| August, 2025 | $7.6676 | $7.7566 | $7.902 | +185.04% |
| September, 2025 | $7.3251 | $7.3951 | $7.5465 | +172.31% |
| October, 2025 | $6.6445 | $6.8295 | $7.2271 | +147.01% |
| November, 2025 | $6.372 | $6.2801 | $6.1864 | +136.88% |
| December, 2025 | $5.8814 | $5.9914 | $6.2326 | +118.64% |
Nrx Pharmaceuticals Inc Stock (NRXP) Price Forecast for 2026
The predicted value for Nrx Pharmaceuticals Inc (NRXP) in 2026 is set at an average of $4.5446. Estimates vary from a peak of $5.7933 to a trough of $3.296, indicating an +68.94% surge from the present price of $2.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.7889 | $5.807 | $5.7933 | +115.20% |
| February, 2026 | $5.8364 | $5.7045 | $5.6708 | +116.97% |
| March, 2026 | $5.7048 | $5.7459 | $5.7701 | +112.07% |
| April, 2026 | $5.4118 | $5.4533 | $5.646 | +101.18% |
| May, 2026 | $5.0508 | $5.0908 | $5.3052 | +87.76% |
| June, 2026 | $4.9763 | $4.9783 | $4.9964 | +84.99% |
| July, 2026 | $4.7818 | $4.7877 | $4.8802 | +77.76% |
| August, 2026 | $4.5401 | $4.5652 | $4.6646 | +68.78% |
| September, 2026 | $4.2396 | $4.2821 | $4.4321 | +57.60% |
| October, 2026 | $3.977 | $3.9896 | $4.1764 | +47.84% |
| November, 2026 | $3.652 | $3.6797 | $3.881 | +35.76% |
| December, 2026 | $3.272 | $3.296 | $3.5215 | +21.63% |
Nrx Pharmaceuticals Inc Stock (NRXP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Nrx Pharmaceuticals Inc (NRXP) is $9.1209, with a high forecast of $18.16 and a low forecast of $0.0841. This indicates an +239.07% increase from the last price of $2.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.9065 | $2.9355 | $3.1908 | +8.05% |
| February, 2027 | $2.7118 | $2.7339 | $2.7717 | +0.81% |
| March, 2027 | $2.3134 | $2.3313 | $2.621 | -14.00% |
| April, 2027 | $2.0258 | $2.0759 | $2.2111 | -24.69% |
| May, 2027 | $2.9116 | $1.8147 | $3.7916 | +8.24% |
| June, 2027 | $10.86 | $0.0841 | $10.19 | +303.72% |
| July, 2027 | $10.63 | $10.72 | $10.81 | +294.98% |
| August, 2027 | $15.73 | $13.52 | $14.59 | +484.76% |
| September, 2027 | $14.16 | $15.14 | $15.66 | +426.48% |
| October, 2027 | $17.01 | $18.04 | $17.50 | +532.48% |
| November, 2027 | $17.63 | $17.22 | $17.08 | +555.35% |
| December, 2027 | $19.23 | $18.16 | $18.16 | +614.78% |
Nrx Pharmaceuticals Inc Stock (NRXP) Price Forecast for 2028
In 2028, Nrx Pharmaceuticals Inc (NRXP) is projected to reach an average price of $16.80, with a high projection of $19.28 and a low estimate of $14.32. This indicates an +524.51% rise from the last price of $2.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $19.43 | $19.27 | $19.28 | +622.40% |
| February, 2028 | $18.92 | $18.72 | $18.67 | +603.26% |
| March, 2028 | $18.35 | $18.25 | $18.28 | +582.02% |
| April, 2028 | $18.66 | $18.41 | $18.37 | +593.73% |
| May, 2028 | $18.98 | $18.53 | $18.93 | +605.60% |
| June, 2028 | $18.38 | $18.44 | $18.56 | +583.28% |
| July, 2028 | $17.90 | $17.93 | $18.23 | +565.51% |
| August, 2028 | $17.06 | $17.08 | $17.73 | +534.07% |
| September, 2028 | $16.52 | $16.60 | $16.88 | +514.27% |
| October, 2028 | $15.90 | $15.96 | $16.24 | +491.04% |
| November, 2028 | $15.17 | $15.20 | $15.74 | +463.86% |
| December, 2028 | $14.01 | $14.32 | $14.83 | +420.92% |
Nrx Pharmaceuticals Inc Stock (NRXP) Price Forecast for 2029
The 2029 price forecast for Nrx Pharmaceuticals Inc Stock (NRXP) is $10.96 on average, with a high prediction of $13.82 and a low estimate of $8.0991. This represents an +307.35% increase from the previous price of $2.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $13.66 | $13.74 | $13.82 | +407.86% |
| February, 2029 | $13.00 | $13.05 | $13.36 | +383.14% |
| March, 2029 | $12.57 | $12.66 | $12.80 | +367.34% |
| April, 2029 | $12.47 | $12.41 | $12.41 | +363.44% |
| May, 2029 | $11.84 | $11.91 | $12.27 | +340.03% |
| June, 2029 | $11.28 | $11.32 | $11.67 | +319.34% |
| July, 2029 | $10.48 | $10.68 | $11.03 | +289.42% |
| August, 2029 | $10.23 | $10.27 | $10.54 | +280.13% |
| September, 2029 | $9.749 | $9.7786 | $10.08 | +262.42% |
| October, 2029 | $9.1628 | $9.1849 | $9.6029 | +240.62% |
| November, 2029 | $8.6569 | $8.6701 | $9.0216 | +221.82% |
| December, 2029 | $8.068 | $8.0991 | $8.4866 | +199.93% |
Nrx Pharmaceuticals Inc Stock (NRXP) Price Forecast for 2030
Nrx Pharmaceuticals Inc Stock (NRXP) is expected to reach an average price of $14.96 in 2030, with a high forecast of $29.45 and a low forecast of $0.4733. This signifies an +456.20% surge from the last price of $2.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.3774 | $7.4017 | $7.9167 | +174.25% |
| February, 2030 | $6.8102 | $6.8217 | $7.2104 | +153.17% |
| March, 2030 | $6.1804 | $6.1867 | $6.6554 | +129.75% |
| April, 2030 | $5.6817 | $5.6917 | $6.0019 | +111.22% |
| May, 2030 | $5.0115 | $5.0846 | $5.5257 | +86.30% |
| June, 2030 | $4.2655 | $4.3655 | $4.7898 | +58.57% |
| July, 2030 | $0.6042 | $0.4733 | $4.1092 | -77.54% |
| August, 2030 | $27.01 | $1.738 | $23.23 | +903.93% |
| September, 2030 | $26.05 | $23.48 | $24.10 | +868.33% |
| October, 2030 | $30.15 | $27.89 | $28.09 | +1,021% |
| November, 2030 | $29.61 | $27.31 | $25.86 | +1,001% |
| December, 2030 | $28.76 | $29.03 | $29.45 | +969.19% |
4.02%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):